MATINAS BIOPHARMA HOLDINGS, INC. Current Liabilities
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) had Current Liabilities of $1.35 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Liabilities, Current $1.35M.
- 2026-03-31: Liabilities, Current $2.13M.
- 2025-12-31: Liabilities, Current $1.46M.
- 2025-09-30: Liabilities, Current $1.50M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.35M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $2.13M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $1.46M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $1.50M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $1.78M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $2.25M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $2.67M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $2.12M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $2.39M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $2.00M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $2.62M 10-K · filed 2025-04-15 | |
| 2023-09-30 | $3.23M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $2.59M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $1.90M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $4.29M 10-K · filed 2024-03-27 | |
| 2022-09-30 | $4.90M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $5.38M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $3.77M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $4.35M 10-K · filed 2023-03-15 | $4.35M 10-K · filed 2022-03-08 |
| 2021-09-30 | $4.10M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $3.59M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $2.22M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $3.57M 10-K/A · filed 2022-03-11 | |
| 2020-09-30 | $2.84M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $2.41M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $2.54M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $3.10M 10-K · filed 2021-03-29 | |
| 2019-09-30 | $2.62M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $3.46M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $3.12M 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $2.84M 10-K · filed 2020-03-09 | |
| 2018-09-30 | $2.64M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $1.49M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $1.03M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $1.77M 10-K · filed 2019-04-01 | $2.22M 10-K · filed 2018-03-16 |
| 2017-09-30 | $1.88M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $1.34M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $1.95M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $1.44M 10-K · filed 2018-03-16 | |
| 2016-09-30 | $1.36M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $1.34M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $1.32M 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $1.13M 10-K · filed 2017-03-31 | |
| 2015-09-30 | $872.77K 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $1.14M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $1.31M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $1.12M 10-K · filed 2016-03-30 | |
| 2014-09-30 | $1.02M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $872.23K 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $673.35K 10-Q · filed 2014-06-06 | |
| 2013-12-31 | $858.97K 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |